Siren, L.L.C. Rocket Pharmaceuticals, Inc. Transaction History
Siren, L.L.C.
- $1.93 Trillion
- Q2 2025
A detailed history of Siren, L.L.C. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 591,263 shares of RCKT stock, worth $1.95 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
591,263
Previous 591,263
-0.0%
Holding current value
$1.95 Million
Previous $3.94 Billion
63.27%
% of portfolio
0.07%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding RCKT
# of Institutions
218Shares Held
98.2MCall Options Held
608KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$58.2 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$27.5 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$20.1 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$15.9 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $249M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...